Articles with "models non" as a keyword



Photo from academic.microsoft.com

Asymptotics for models of non‐stationary diffusion in domains with a surface distribution of obstacles

Sign Up to like & get
recommendations!
Published in 2018 at "Mathematical Methods in the Applied Sciences"

DOI: 10.1002/mma.5323

Abstract: The authors would like to thank the anonymous referees for their careful reading of the manupscript and useful comments. The work has been partially supported by MINECO, MTM2013-44883-P. read more here.

Keywords: models non; diffusion domains; non stationary; stationary diffusion ... See more keywords
Photo by googledeepmind from unsplash

Antisteatotic and antioxidant activities of Thymbra spicata L. extracts in hepatic and endothelial cells as in vitro models of non-alcoholic fatty liver disease.

Sign Up to like & get
recommendations!
Published in 2019 at "Journal of ethnopharmacology"

DOI: 10.1016/j.jep.2019.111919

Abstract: ETHNOPHARMACOLOGICAL RELEVANCE Thymbra spicata, a member of the Lamiaceae family, is native to eastern Mediterranean area. Leaves of this plant are rich in phenolic compounds and are a popular remedy of traditional medicine in Lebanon… read more here.

Keywords: thymbra spicata; models non; antisteatotic antioxidant; antioxidant activities ... See more keywords
Photo by lukechesser from unsplash

High-dimensional rank-based graphical models for non-Gaussian functional data

Sign Up to like & get
recommendations!
Published in 2023 at "Statistics"

DOI: 10.1080/02331888.2023.2201009

Abstract: We study high-dimensional graphical models for non-Gaussian functional data. To relax the Gaussian assumption, we consider the functional Gaussian copula graphical model proposed by Solea and Li [Copula Gaussian graphical models for functional data. J… read more here.

Keywords: models non; functional data; rank based; high dimensional ... See more keywords
Photo from wikipedia

Abstract 1522: The CDK4/6 inhibitor G1T38 enhances response to targeted therapies in preclinical models of non-small cell lung cancer

Sign Up to like & get
recommendations!
Published in 2018 at "Cancer Research"

DOI: 10.1158/1538-7445.am2018-1522

Abstract: The recent FDA approvals of palbociclib, ribociclib, and abemaciclib in breast cancer validate cyclin-dependent kinases 4 and 6 (CDK4/6) as key therapeutic targets, and warrant investigations in other tumor types with frequently observed alterations in… read more here.

Keywords: cdk4 inhibitor; models non; response; cancer ... See more keywords